Table 4. Logistic regression model: Predictors of a favorable TB treatment outcome (defined as cured or treatment completed), at Carmelo Hospital between January 1, 2006 and December 31, 2017.
| Estimates from Logistic regression models | ||||||
|---|---|---|---|---|---|---|
| Variables | Unadjusted | Adjusted | ||||
| OR (95% CI) | p-value | aOR (95% CI) | p-value | |||
| Gender | <0.001 | |||||
| Female | 1 | 1 | ||||
| Male | 0.76 | (0.70–0.84) | <0.001 | 0.74 | (0.67–0.82) | |
| Age | 0.05 | |||||
| 15–24 | 1 | 1 | ||||
| 25–64 | 0.78 | (0.67–0.91) | <0.01 | 0.89 | (0.76–1.05) | |
| 65+ | 0.84 | (0.65–1.09) | 0.2 | 0.72 | (0.54–0.94) | |
| TB Diagnosis | 0.001 | |||||
| New Diagnosis | 1 | 1 | ||||
| All Others | 0.73 | (0.63–0.83) | <0.001 | 0.76 | (0.65–0.89) | |
| TB type | 0.02 | |||||
| Clinically diagnosed | 1 | |||||
| Bacteriologically confirmed | 1.16 | (1.05–1.29) | <0.01 | 1.16 | (1.03–1.29) | |
| Extrapulmonary | 1.11 | (0.99–1.25) | 0.07 | 1.09 | (0.97–1.25) | |
| HIV status* | ||||||
| HIV (-) | 1 | |||||
| HIV (+) | 0.54 | (0.47–0.61) | <0.001 | |||
| HIV/ART status with ATT timing1 | <0.001 | |||||
| HIV (-) | 1 | 1 | ||||
| HIV (+) / ART never started | 0.14 | (0.12–0.18) | <0.001 | 0.15 | (0.12–0.17) | |
| HIV (+) / on ART at treatment start ≤90 days | 0.37 | (0.30–0.45) | <0.001 | 0.37 | (0.29–0.45) | |
| HIV (+) / on ART at treatment start >90 days | 0.50 | (0.43–0.59) | <0.001 | 0.50 | (0.41–0.59) | |
| HIV (+) / ART Naïve at treatment start but started on ART | 0.90 | (0.78–1.05) | 0.19 | 0.89 | (0.76–1.04) | |
| Year | <0.001 | |||||
| 2005–2018 (every yearly increase) | 1.03 | (1.01–1.04) | <0.001 | 1.03 | (1.02–1.05) | |
| Distance from health facility | <0.001 | |||||
| Every 10km increase | 0.95 | (0.93–0.97) | <0.001 | 0.96 | (0.94–0.98) | |
1ART–Antiretroviral treatment, ATT–Anti-tuberculosis Treatment
*Not included in the model as correlated to HIV status and ART/ATT treatment timing